Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139


Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior.

Mineur YS, Obayemi A, Wigestrand MB, Fote GM, Calarco CA, Li AM, Picciotto MR.

Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3573-8. doi: 10.1073/pnas.1219731110. Epub 2013 Feb 11.


SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway.

Jiang B, Wang F, Yang S, Fang P, Deng ZF, Xiao JL, Hu ZL, Chen JG.

Int J Neuropsychopharmacol. 2014 Dec 7;18(6). pii: pyu096. doi: 10.1093/ijnp/pyu096.


Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine.

Mineur YS, Einstein EB, Bentham MP, Wigestrand MB, Blakeman S, Newbold SA, Picciotto MR.

Neuropsychopharmacology. 2015 Mar;40(4):938-46. doi: 10.1038/npp.2014.269. Epub 2014 Oct 7.


Nrf2-signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety/depression.

Mendez-David I, Tritschler L, Ali ZE, Damiens MH, Pallardy M, David DJ, Kerdine-Römer S, Gardier AM.

Neurosci Lett. 2015 Jun 15;597:121-6. doi: 10.1016/j.neulet.2015.04.036. Epub 2015 Apr 24.


Rosmarinus officinalis L. hydroalcoholic extract, similar to fluoxetine, reverses depressive-like behavior without altering learning deficit in olfactory bulbectomized mice.

Machado DG, Cunha MP, Neis VB, Balen GO, Colla AR, Grando J, Brocardo PS, Bettio LE, Dalmarco JB, Rial D, Prediger RD, Pizzolatti MG, Rodrigues AL.

J Ethnopharmacol. 2012 Aug 30;143(1):158-69. doi: 10.1016/j.jep.2012.06.017. Epub 2012 Jun 18.


Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801.

Farley S, Dumas S, El Mestikawy S, Giros B.

Neuropharmacology. 2012 Jan;62(1):503-17. doi: 10.1016/j.neuropharm.2011.09.010. Epub 2011 Sep 17.


Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization.

Greene J, Banasr M, Lee B, Warner-Schmidt J, Duman RS.

Neuropsychopharmacology. 2009 Oct;34(11):2459-68. doi: 10.1038/npp.2009.68. Epub 2009 Jun 24.


Antidepressant-like effects of oleoylethanolamide in a mouse model of chronic unpredictable mild stress.

Jin P, Yu HL, Tian-Lan, Zhang F, Quan ZS.

Pharmacol Biochem Behav. 2015 Jun;133:146-54. doi: 10.1016/j.pbb.2015.04.001. Epub 2015 Apr 10.


Hippocampal and behavioral dysfunctions in a mouse model of environmental stress: normalization by agomelatine.

Boulle F, Massart R, Stragier E, Païzanis E, Zaidan L, Marday S, Gabriel C, Mocaer E, Mongeau R, Lanfumey L.

Transl Psychiatry. 2014 Nov 25;4:e485. doi: 10.1038/tp.2014.125.


Antidepressant-like effects of guanfacine and sex-specific differences in effects on c-fos immunoreactivity and paired-pulse ratio in male and female mice.

Mineur YS, Bentham MP, Zhou WL, Plantenga ME, McKee SA, Picciotto MR.

Psychopharmacology (Berl). 2015 Oct;232(19):3539-49. doi: 10.1007/s00213-015-4001-3. Epub 2015 Jul 7.


The effects of antidepressant treatment in prenatally stressed rats support the glutamatergic hypothesis of stress-related disorders.

Marrocco J, Reynaert ML, Gatta E, Gabriel C, Mocaër E, Di Prisco S, Merega E, Pittaluga A, Nicoletti F, Maccari S, Morley-Fletcher S, Mairesse J.

J Neurosci. 2014 Feb 5;34(6):2015-24. doi: 10.1523/JNEUROSCI.4131-13.2014.


Mice deficient for wild-type p53-induced phosphatase 1 display elevated anxiety- and depression-like behaviors.

Ruan CS, Zhou FH, He ZY, Wang SF, Yang CR, Shen YJ, Guo Y, Zhao HB, Chen L, Liu D, Liu J, Baune BT, Xiao ZC, Zhou XF.

Neuroscience. 2015 May 7;293:12-22. doi: 10.1016/j.neuroscience.2015.02.037. Epub 2015 Feb 27.


PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13.

Lu Y, Wang C, Xue Z, Li C, Zhang J, Zhao X, Liu A, Wang Q, Zhou W.

Int J Neuropsychopharmacol. 2014 Dec 25;18(5). pii: pyu110. doi: 10.1093/ijnp/pyu110.


Ventral tegmental area muscarinic receptors modulate depression and anxiety-related behaviors in rats.

Small KM, Nunes E, Hughley S, Addy NA.

Neurosci Lett. 2016 Mar 11;616:80-5. doi: 10.1016/j.neulet.2016.01.057. Epub 2016 Jan 29.


Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors.

García-Gutiérrez MS, Pérez-Ortiz JM, Gutiérrez-Adán A, Manzanares J.

Br J Pharmacol. 2010 Aug;160(7):1773-84. doi: 10.1111/j.1476-5381.2010.00819.x.


Blockade of protein phosphatase 2B activity in the amygdala increases anxiety- and depression-like behaviors in mice.

Bahi A, Mineur YS, Picciotto MR.

Biol Psychiatry. 2009 Dec 15;66(12):1139-46. doi: 10.1016/j.biopsych.2009.07.004. Epub 2009 Aug 28. Retraction in: Biol Psychiatry. 2014 Jun 15;75(12):999.


Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors.

Venzala E, García-García AL, Elizalde N, Delagrange P, Tordera RM.

Psychopharmacology (Berl). 2012 Nov;224(2):313-25. doi: 10.1007/s00213-012-2754-5. Epub 2012 Jun 16.


Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system.

Gupta D, Radhakrishnan M, Kurhe Y.

Eur J Pharmacol. 2014 Dec 5;744:59-66. doi: 10.1016/j.ejphar.2014.09.041. Epub 2014 Oct 2.


Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress.

Moretti M, Colla A, de Oliveira Balen G, dos Santos DB, Budni J, de Freitas AE, Farina M, Severo Rodrigues AL.

J Psychiatr Res. 2012 Mar;46(3):331-40. doi: 10.1016/j.jpsychires.2011.11.009. Epub 2011 Dec 9.


Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand JP, Soubrie P.

Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6370-5. Epub 2002 Apr 16.

Items per page

Supplemental Content

Write to the Help Desk